Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001960048-26-000013

SVP, Finance & CAO sold 19,000 shares at $86.74 ($1,648,060)

  • SVP, Finance & CAO acquired 19,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Cowan Elvia · SVP, Finance & CAO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-05 Exercise or conversion : show line 1 in the form 10b5-1 +19,000 $25.92 $492,480 46,860 D
2026-10-05 Sale : show line 2 in the form 10b5-1 −19,000 $86.74 $1,648,060 27,860 D
Open-market sales · 19,000 sh · avg $86.74 · $1,648,060

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-05 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −19,000 74,068 D
Loading xslF345X06/wk-form4_1791403671.xml…